Marco Mura is an Ophthalmologist in Baltimore, Maryland. Dr. Mura is rated as an Elite provider by MediFind in Vitrectomy. His top areas of expertise are Retinal Detachment, Knobloch Syndrome, Pulmonary Fibrosis, Vitrectomy, and Cataract Removal.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is rated as an Advanced provider by MediFind in Vitrectomy. Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Advanced provider by MediFind in Vitrectomy. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Interstitial Keratitis, Cataract, Optic Nerve Atrophy, Vitrectomy, and Cataract Removal.

Mira M. Sachdeva, M.D., Ph.D. specializes in the medical and surgical management of diseases of the retina, including diabetic retinopathy, macular degeneration, retinal vascular occlusions, retinal detachments, macular holes, and epiretinal membranes. Her research efforts are directed towards developing new treatments to prevent or reverse the retinal neurodegeneration and vision loss that occurs in patients with diabetes. Dr. Sachdeva’s ultimate goal is to identify strategies for neuroprotection that are broadly applicable to other conditions in which the retina is irreversibly damaged, including macular degeneration and retinal detachment. Dr. Sachdeva received her medical degree from the University of Pennsylvania medical school. She completed her residency at the Wilmer Eye Institute in 2014. Thereafter, she completed a fellowship at the Massachusetts Ear and Eye Infirmary. Dr. Sachdeva is currently a Wilmer Rising Professor in Ophthalmology. Videos Dr. SachdevaOphthalmology Recent News Articles and Media Coverage Bridging the Gap, Wilmer Magazine (July 2019). Dr. Sachdeva is rated as an Advanced provider by MediFind in Vitrectomy. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Mustafa Iftikhar, M.D., is the Stephen J. Ryan Assistant Chief of Service and assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Iftikhar completed his ophthalmology residency at Wilmer, followed by a vitreoretinal surgery fellowship at Duke University Hospital. His clinical approach is rooted in patient-centered and evidence-based care. Dr. Iftikhar’s research interests include retinal diseases, ocular trauma, and healthcare disparities. He is deeply committed to surgical education and takes great pride in mentoring the next generation of ophthalmologists. Dr. Iftikhar is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in Vitrectomy. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Taariq Mohammed is an Ophthalmologist in Baltimore, Maryland. Dr. Mohammed is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Vitrectomy. Dr. Mohammed is currently accepting new patients.

Nakul Shekhawat, M.D., M.P.H. is an ophthalmologist and eye surgeon at the Johns Hopkins Wilmer Eye Institute and the 2023 Stephen F Raab and Mariellen Brickley-Raab Rising Professor of Ophthalmology. He specializes in cataract surgery, complex cataract and anterior segment surgery, corneal and external diseases, and corneal surgery including both full- and partial-thickness corneal transplantation (DMEK, DSAEK, DALK, PKP). Dr. Shekhawat received his M.D. degree from Vanderbilt University School of Medicine and his M.P.H. degree in epidemiology and biostatistics from the Johns Hopkins Bloomberg School of Public Health. He completed ophthalmology residency at the renowned Kellogg Eye Center, University of Michigan where he received the Resident Excellence Award from the American Society of Cataract and Refractive Surgery. He completed additional subspecialty training in cornea, external disease, and refractive surgery at the Wilmer Eye Institute where he was awarded the prestigious Claes Dohlman Award from Harvard Medical School recognizing the most outstanding cornea fellow in the country. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Shekhawat_CV.pdf Recent News Articles and Media Coverage Laser cataract surgery now offered in Bethesda- Hopkins Medicine (April 2024) Johns Hopkins, Microsoft Extend Collaboration for Startups as Newest Grant Recipients Named - Johns Hopkins Technology Ventures (July 2021) Taking a Wide View with Nakul Shekhawat - Hopkins Medicine (September 2020) A Patient’s Guide to Shingles: Prompt treatment is crucial to avoid severe neurological complications - US News & World Report (January 2020) Shingle White Female: Study finds three-fold increase in number of Americans diagnosed with shingles - The Ophthalmologist (July 2019). Dr. Shekhawat is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Interstitial Keratitis, Cataract, Amebiasis, Cataract Removal, and Vitrectomy.

Majed Alkharashi is an Ophthalmologist in Baltimore, Maryland. Dr. Alkharashi is rated as an Advanced provider by MediFind in Vitrectomy. His top areas of expertise are Cataract, Interstitial Keratitis, Astigmatism, Corneal Transplant, and Vitrectomy.

Neil R. Miller, M.D., is Professor of Ophthalmology, Neurology & Neurosurgery. He specializes in neuro-ophthalmology and orbital disease. Dr. Miller received his M.D. degree from the Johns Hopkins University School of Medicine and completed his residency in ophthalmology at the Wilmer Eye Institute, where he also served as chief resident. He completed a fellowship in neuro-ophthalmology at the University of CA, San Francisco. He has been a member of the Wilmer faculty since 1976. Dr. Miller is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Increased Intracranial Pressure, Benign Essential Blepharospasm, Papilledema, Vitrectomy, and Cataract Removal.

Elia J. Duh, M.D., is the G. Edward and G. Britton Durell Professor of Ophthalmology at the Wilmer Eye Institute. He has a joint appointment in the Department of Chemical and Biomolecular Engineering, The Whiting School of Engineering. He specializes in diseases of the retina, including diabetic retinopathy and age-related macular degeneration. In addition to his clinical practice, Dr. Duh actively researches the molecular mechanisms underlying diabetic retinopathy and macular degeneration, particularly the process of ocular neovascularization and excessive retinal vascular permeability. His research has helped determine the role of the major antioxidant regulator, Nrf2, in retinal diseases, and also connected Nrf2 to lifespan. His work has also provided insights into the involvement of the eye in COVID-19. Dr. Duh’s interest in developing new treatments for retinal diseases includes nanomedicine approaches for targeted drug delivery to the eye. Dr. Duh graduated summa cum laude from Yale University and obtained his medical degree from Harvard Medical School. He completed his ophthalmology residency and medical retina fellowship at the Wilmer Eye Institute. He was elected to the American Society of Clinical Investigation in 2016. Dr. Duh is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Vitrectomy.

Ankit Garg is a Cardiologist in Baltimore, Maryland. Dr. Garg has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in Vitrectomy. His top areas of expertise are Dilated Cardiomyopathy (DCM), Double Outlet Right Ventricle, Double Outlet Left Ventricle, Cardiomyopathy, and Vitrectomy.